Fundraising FoxApexigen
San Carlos, US · Founded 2020 · 7 known investors
Find your way into Apexigen
Sign up to see every warm intro you have to Apexigen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Apexigen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Apexigen was founded in 2020 by Xiaodong Yang.
Board
Investors · 7
How we know: EFung Capital's portfolio page · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$51.4M disclosed across 2 of 3 rounds · 2018–2023
- Undisclosed amountSeries BAug 2018
3E Bioventures Capital (lead), Decheng Capital (lead), SV Tech Ventures (lead), Virtus Inspire Ventures (lead)
Source ↗
▶$5.6MraisedFeb 2023 · 13 investors · BiotechnologyRule 506(b)
- Gordon RingoldDirector
- Scott SmithDirector
- Herb CrossDirector
- Francis SarenaExecutive Officer
- Jakob DupontDirector
- Xiaodong YangExecutive Officer, Director
- Amy WongExecutive Officer
- Meenu KarsonDirector
- Frank HsuExecutive Officer
- Samuel WertheimerDirector
- William Duke, Jr.Executive Officer
- Dan ZabrowskiDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- Sales commissions
- $195.6K
- Finders' fees
- $45K
- Placement agents
- Brookline Capital Markets, a division of Arcadia Securities, LLC
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$45.8MraisedDec 2019 · 19 investors · BiotechnologyRule 506(b)
- Ovid TrifanExecutive Officer
- Amy WongExecutive Officer
- Herb CrossDirector
- Scott SmithDirector
- Dan ZabrowskiDirector
- Karen LiuDirector
- Kenneth FongDirector
- William RutterDirector
- Xiaodong YangExecutive Officer, Director
- Offering amount
- $70M
- Amount sold
- $45.8M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Apexigen?
- Apexigen was founded by Xiaodong Yang in 2020.
- Who are Apexigen's investors?
- Apexigen's investors include EFung Capital, ShangBay Capital LLC, SVE Capital, 3E Bioventures Capital, Decheng Capital, Sv Tech Ventures, Inc., Virtus Inspire Ventures.
- How much funding has Apexigen raised?
- Apexigen has disclosed $51.4M raised across 2 of its 3 known rounds.
- Where is Apexigen headquartered?
- Apexigen is headquartered in San Carlos, US.